APA (7th ed.) Citation

Tzellos, T., Giamarellos‐Bourboulis, E. J., Straalen, K. R., Martorell, A., Kirby, B., Alavi, A., . . . Zouboulis, C. C. (2026). Bimekizumab efficacy using IHS4 outcomes in hidradenitis suppurativa: Results from BE HEARD I and II. Journal of the European Academy of Dermatology & Venereology, 1. https://doi.org/10.1111/jdv.70356

Chicago Style (17th ed.) Citation

Tzellos, Thrasyvoulos, et al. "Bimekizumab Efficacy Using IHS4 Outcomes in Hidradenitis Suppurativa: Results from BE HEARD I and II." Journal of the European Academy of Dermatology & Venereology 2026: 1. https://doi.org/10.1111/jdv.70356.

MLA (9th ed.) Citation

Tzellos, Thrasyvoulos, et al. "Bimekizumab Efficacy Using IHS4 Outcomes in Hidradenitis Suppurativa: Results from BE HEARD I and II." Journal of the European Academy of Dermatology & Venereology, 2026, p. 1, https://doi.org/10.1111/jdv.70356.